A*STAR and Cytos Biotechnology AG Bring Singapore's First Influenza Vaccine to Clinical Testing
5/17/2013 9:07:43 AM
More...
|
Cytos Biotechnology AG Reports First Quarter 2013 Financial Results and Recent Development
4/25/2013 6:53:41 AM
More...
|
The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnology AG’s CYT003 for the Treatment of Allergic Asthma
3/13/2013 9:34:58 AM
More...
|
Cytos Biotechnology AG VLP Platform is Basis for Phase 1 Clinical Trial with Anti-IgE Vaccine
2/4/2013 9:44:06 AM
More...
|
Cytos Biotechnology AG Reports Third Quarter 2012 Financial Results, Recent Development and Outlook
11/6/2012 10:20:06 AM
More...
|
Cytos Biotechnology AG Appoints Dr. Christian Itin as Chief Executive Officer
10/9/2012 6:35:40 AM
More...
|
Cytos Biotechnology AG Reports Second Quarter 2012 Financial Results, Recent Development and Outlook
7/30/2012 10:40:49 AM
More...
|
Cytos Biotechnology AG to Raise Up to $40 Million to Advance Phase II Asthma Immunotherapy
3/21/2012 7:35:58 AM
More...
|
Cytos Biotechnology AG Makes 80% Workforce Cut and Halts All in House Programs Except Lead Allergy Drug
8/17/2011 6:43:03 AM
More...
|
A*STAR & Cytos Biotechnology AG Establish Influenza Vaccine Collaboration
7/15/2010 1:29:11 PM
More...
|
|